Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuron Disease, Motor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnrolling By InvitationNCT07567664
What this trial is testing

Tracking and Predicting How Brain Damage Spreads in Neurodegenerative Diseases

Who this might be right for
Neurodegenerative DiseaseBehavioral Variant Frontotemporal Dementia (bvFTD)Primary Progressive Aphasia(PPA)+3 more
IRCCS San Raffaele 645
Not applicableUnknownNCT06320444
What this trial is testing

Non-invasive Spinal, Cortical, and Sensorimotor Biomarkers in Motor Neurone Disease

Who this might be right for
Motor Neuron Disease, Amyotrophic Lateral SclerosisMotor Neuron Disease Progressive Spinal Muscle AtrophyPrimary Lateral Sclerosis+2 more
University of Dublin, Trinity College 240
Not applicableStudy completedNCT00015444
What this trial is testing

Screening and Natural History: Primary Lateral Sclerosis and Related Disorders

Who this might be right for
Primary Lateral Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 189
Not applicableStudy completedNCT02916966
What this trial is testing

Environmental Exposure and Neurological Diseases Questionnaire

Who this might be right for
Amyotrophic Lateral Sclerosis
Dartmouth-Hitchcock Medical Center 460
Testing effectiveness (Phase 2)Looking for participantsNCT06249867
What this trial is testing

Assess the Safety, Tolerability, and Pharmacology of Darifenacin in Patients With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Oliver Blanchard 30
Large-scale testing (Phase 3)Study completedNCT01776970
What this trial is testing

Safety and Efficacy on Spasticity Symptoms of a Cannabis Sativa Extract in Motor Neuron Disease

Who this might be right for
Motor Neuron DiseaseAmyotrophic Lateral Sclerosis (ALS)
Ospedale San Raffaele 60
Testing effectiveness (Phase 2)Temporarily pausedNCT03755167
What this trial is testing

A Follow up Study to Protocol 101/2 - Continued Treatment by IPL344 IV

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Immunity Pharma Ltd. 15
Early research (Phase 1)WithdrawnNCT02588807
What this trial is testing

Food Supplement for the Treatment of Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Herb Spirit
Not applicableUnknownNCT03806634
What this trial is testing

Development and Needs Assessment and Efficiency of Smart Communication System for Patients With ALS (Part 2)

Who this might be right for
Amyotrophic Lateral Sclerosis
Taipei Veterans General Hospital, Taiwan 20
Not applicableApproved For MarketingNCT04256265
What this trial is testing

An Expanded Access Program for Risdiplam in Participants With Spinal Muscular Atrophy (SMA)

Who this might be right for
Muscular Atrophy, Spinal
Genentech, Inc.
Not applicableStudy completedNCT05237544
What this trial is testing

Newborn Screening for Spinal Muscular Atrophy (SMA) - a Proof of Principle Study Using Anonymised Blood Spots.

Who this might be right for
Spinal Muscular Atrophy
Great Ormond Street Hospital for Children NHS Foundation Trust 5,065
Not applicableStudy completedNCT03382392
What this trial is testing

Hypermetabolism in ALS Using Six REE Formulas

Who this might be right for
Amyotrophic Lateral Sclerosis
University Hospital, Limoges 449
Not applicableStudy completedNCT03694132
What this trial is testing

Brain Excitability and Connectivity in Sensory-motor Pathways in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Institut National de la Santé Et de la Recherche Médicale, France 52
Testing effectiveness (Phase 2)Study completedNCT00800501
What this trial is testing

A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Newron Sweden AB 18
Testing effectiveness (Phase 2)WithdrawnNCT02116634
What this trial is testing

Mesenchymal Stem Cell Injection in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Alzahra Hospital, Iran
Testing effectiveness (Phase 2)UnknownNCT06108193
What this trial is testing

Toxicity and Efficacy Evaluation of Topical Minoxidil in Acne Vulgaris

Who this might be right for
Acne Vulgaris
Chang Gung Memorial Hospital 26
Not applicableActive Not RecruitingNCT02327845
What this trial is testing

Phenotype, Genotype & Biomarkers in ALS and Related Disorders

Who this might be right for
Amyotrophic Lateral SclerosisFrontotemporal DementiaPrimary Lateral Sclerosis+3 more
University of Miami 708
Not applicableStudy completedNCT01984957
What this trial is testing

Differential Study of Muscle Transcriptome

Who this might be right for
ALSSMASBMA
Assistance Publique - Hôpitaux de Paris 42
Testing effectiveness (Phase 2)Study completedNCT01369901
What this trial is testing

Effect of Functional Exercise in Patients With Spinal Bulbar Muscular Atrophy

Who this might be right for
Motor Neuron Disease
National Institute of Neurological Disorders and Stroke (NINDS) 61
Not applicableEnrolling By InvitationNCT06875739
What this trial is testing

An Innovative Method in SAliva Samples for the Early Differential Diagnosis of High-impact NeuroDegenerative Diseases Through Raman Spectroscopy

Who this might be right for
Neurodegenerative DisordersParkinson DiseaseAlzheimer Disease+3 more
Fondazione Don Carlo Gnocchi ETS 310
Next Page